Aim: The formulary inclusion of direct oral anticoagulant (DOACs) in the government hospital
health services in Qatar is not comparative or restricted. Requests to include a DOAC in the …

Direct oral anticoagulants (DOACs) are more commonly prescribed since their introduction.
Reports on inappropriate prescribing have been observed which may indicate poor …

OBJECTIVE: This study aimed to assess the appropriateness of direct oral anticoagulants
(DOACs) utilization in a Saudi tertiary hospital. PATIENTS AND METHODS: Adult inpatients …

Pharmacists were found to play a key role in anticoagulation care. In order to make an
appropriate selection and counselling regarding direct oral anticoagulants (DOACs) …

Abstract Background Direct oral anticoagulants (DOACs) are considered high-risk
medications and used to prevent thromboembolic events and stroke. This study aimed to …

In Qatar, dabigatran was introduced in 2011 followed by rivaroxaban in 2014. In this study,
we aim to explore the trends in oral anticoagulant use in Qatar over the past 5 years and to …

Objectives Direct oral anticoagulants (DOACs), including apixaban, rivaroxaban, dabigatran,
edoxaban, are alternative anticoagulant therapies to warfarin in United States (US) to …

Aims This study aimed to evaluate the prescriber compliance to the approved labels of direct
oral anticoagulants (DOACs) and impact of appropriateness of dosing on clinical outcomes …

Background Information on inappropriate dosing of direct oral anticoagulants (DOACs) is
scarce in the Australian context. Aim To describe the prevalence and potential predictors of …

ABSTRACT Introduction: Direct oral anticoagulants (DOACs) constitute a first-line therapy in
non-valvular atrial fibrillation and venous thromboembolic disease. The aim of this study was …